Mailing Address:

Research Associate Professor
Child Health Evaluation and Research Unit
Division of General Pediatrics
University of Michigan Health System
300 N. Ingalls St., Room 6E14, SPC 5456
Ann Arbor, MI 48109

Phone: 734-232-1077
Fax: 734-764-2599
Email: lisapros@med.umich.edu

Current CV in PDF Format:
Lisa Prosser CV 2008-2-11

Lisa Prosser, Ph.D.

Lisa Prosser, Ph.D., is an Adjunct Assistant Professor in the Department of Ambulatory Care and Prevention. She is currently a Research Scientist at the Center for Health Services Research at Henry Ford Health System. Dr. Prosser's major research interests are (1) economic evaluations of health interventions and (2) methods for valuing changes in health. Her current research focuses on policy-relevant topics concerning the cost-effectiveness of childhood interventions, including influenza vaccination and newborn screening. Dr. Prosser's research on the economic impact of influenza vaccination has been used in setting national vaccine policy for children and for prioritizing subgroups in vaccine shortage years. Current research projects include a national survey on public values for preventing influenza illness and an evaluation of the cost-effectiveness of expanded newborn screening programs that includes parental stress and anxiety associated with false positive test results.

Another goal in Dr. Prosser's research is to advance the methods of valuing health for cost-effectiveness analysis, particularly for children's health states. One project underway is testing new approaches for valuing temporary health states using a discrete choice experiment.

Dr. Prosser received her Ph.D. in health policy from Harvard University. She also holds a M.S. degree from the MIT Sloan School of Management and a M.S. from the Technology and Policy Program at MIT. Her undergraduate degree is in mathematics from Cornell University.

Select publications:

• Prosser LA, Bridges CB, Uyeki TM, Rego VH, Ray GT, Meltzer MI, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes. 2005;3(18):1-16. Available at: http://www.hqlo.com/content/3/1/18
• Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12(10):1548-1558.
• Prosser LA, Wittenberg E. Do risk attitudes differ across domains and respondent types? Med Decis Making. 2007;27(3):281-287.
• Prosser LA, Corso PS. Measuring health-related quality of life for child maltreatment: A systematic literature review. Health Qual Life Outcomes. 2007;5(1)1-17. Available at: http://www.hqlo.com/content/5/1/42.
• Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and benefit analyses of interventions in children: Theoretical and methodological considerations. Pharmacoeconomics. 2007;25(9):713-726.
• Ladapo JA, Neumann PJ, Keren R, Prosser LA. Valuing children’s health: a comparison of cost-utility analyses for adult and pediatric health interventions. Pharmacoeconomics. 2007;25(10):817-828.
• Prosser LA, O’Brien MA, Molinari NA, Hohman KH, Nichol KL, Wortley PM, Messonnier ML, Lieu TA. Cost-effectiveness of delivering adult influenza vaccination in non-traditional settings. Pharmacoeconomics. 2008;26(2):163-178.
• Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA. Community and patient values for preventing zoster. Pharmacoeconomics. In press.
• Prosser LA, Ladapo JA, Rusinak D, Waisbren SE. Parental tolerance for false-positive newborn screening results. Arch Pediatr Adolesc Med. In press.